Most processed, e.g. fucosylated, N-glycans on insect glycoproteins terminate in mannose, yet the relevant modifying enzymes require the prior action of N-acetylglucosaminyltransferase I. This led to the hypothesis that a hexosaminidase acts during the course of N-glycan maturation. To determine whether the Drosophila melanogaster genome indeed encodes such an enzyme, a cDNA corresponding to fused lobes (fdl), a putative -N-acetylglucosaminidase with a potential transmembrane domain, was cloned. When expressed in Pichia pastoris, the enzyme exhibited a substrate specificity similar to that previously described for a hexosaminidase activity from Sf-9 cells, i.e. it hydrolyzed exclusively the GlcNAc residue attached to the ␣1,3-linked mannose of the core pentasaccharide of N-glycans. It also hydrolyzed p-nitrophenyl-N-acetyl--glucosaminide, but not chitooligosaccharides; in contrast, Drosophila HEXO1 and HEXO2 expressed in Pichia cleaved both these substrates but not N-glycans. The localization of recombinant FDL tagged with green fluorescent protein in Drosophila S2 cells by immunoelectron microscopy showed that this enzyme transits through the Golgi, is present on the plasma membrane and in multivesicular bodies, and is secreted. Finally, the N-glycans of two lines of fdl mutant flies were analyzed by mass spectrometry and reversed-phase high-performance liquid chromatography. The ratio of structures with terminal GlcNAc over those without (i.e. paucimannosidic N-glycans) was drastically increased in the fdldeficient flies. Therefore, we conclude that the fdl gene encodes a novel hexosaminidase responsible for the occurrence of paucimannosidic N-glycans in Drosophila.Insect cells are considered to be an interesting alternative to mammalian, yeast, or bacterial cells for the expression of recombinant proteins (1, 2), because the potentially high levels of expression are associated with the ability to perform many eukaryotic post-translational modifications. Nevertheless, glycoproteins produced in insects and insect cells have been mainly found to carry paucimannosidic N-glycans, i.e. glycans consisting of the pentasaccharide core with or without ␣1,6-and/or ␣1,3-linked fucose (1, 3-5). In addition to the possible presence of the immunogenic core ␣1,3-linked fucose, the lack of complex type N-glycans with complete, sialylated antennae as found on mammalian glycoproteins makes insect cells unsuitable for the production of many therapeutic glycoproteins (6).Only in a few cases have substitutions of the terminal mannose residues of insect N-glycans been described. The most common substitution is the presence of terminal GlcNAc on the ␣1,3-linked mannosyl residue (GlcNAc-1) 3 added by GlcNAc-transferase I, although in a few cases further modifications such as galactose, N-acetylgalactosamine, fucose, and aminoethylphosphonate (i.e. phosphorylethanolamine) have been found linked to this GlcNAc residue (7-11). The occurrence of larger and sialylated N-glycans has been reviewed elsewhere (1, 4). In most instances, howe...